CureMelanoma.org
Toggle Navigation
Numbers & Timeline
Leading the Charge
Reflecting on a Decade of Progress and Future Heights
The Power of Synergy: Moving LAG-3 from Bench to Bedside
Adjuvant Therapy: Is More Better or is Less More?
Keeping Rare Melanomas Front and Center: Tebentafusp and Other Advances
Hot Rod Charlie and How Partnerships Move the Field Forward
2022 MRA Awards
Team Science Awards
Team Science Academic Industry Partnership Awards
Young Investigator Awards
Pilot Awards
Dermatology Fellows Awards
Dermatology Junior Faculty/Clinical Instructor Awards
The People of MRA
MRA Board of Directors
MRA Team
Melanoma > Exchange Community Leaders
MRA Scientific Advisory Panel 2022-2023
MRA Medical Advisory Panel 2022-2023
MRA Dermatology Council 2022-2023
Grant Review Committee 2022-2023
RARE Oversight Committee
Donors & Tributes
Donors & Supporters
Tributes & Memorials
Financials
2022 Leading the Charge
Emmanuel Lerma
January 9, 2023
February 1, 2023
Leading the Charge
Reflecting on a Decade of Progress and Future Heights
Read More
The Power of Synergy: Moving LAG-3 from Bench to Bedside
Read More
Adjuvant Therapy: Is More Better Or Is Less More?
Read More
Keeping Rare Melanomas Front and Center: Tebentafusp and Other Advances
Read More
Hot Rod Charlie and How Partnerships Move the Field Forward
Read More
CLOSE